| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1043822218 |
| P356 | DOI | 10.1007/S40264-013-0076-0 |
| P698 | PubMed publication ID | 23771795 |
| P50 | author | Chia-Hsuin Chang | Q56614609 |
| P2093 | author name string | Mei-Shu Lai | |
| Ming-Fong Chen | |||
| Chao-Lun Lai | |||
| Wen-Yi Shau | |||
| P2860 | cites work | A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 |
| Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins | Q29547856 | ||
| Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials | Q29617910 | ||
| Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database | Q33867311 | ||
| Blindness due to cataract: epidemiology and prevention | Q34390116 | ||
| Statin use and incident nuclear cataract | Q34540388 | ||
| Age-related cataract is associated with type 2 diabetes and statin use. | Q34640394 | ||
| Racial differences in lens opacities: the Salisbury Eye Evaluation (SEE) project | Q34755761 | ||
| Medical lipid-regulating therapy: current evidence, ongoing trials and future developments | Q35782818 | ||
| Annualized was found better than absolute risk reduction in the calculation of number needed to treat in chronic conditions | Q36400888 | ||
| The new epidemiology of cataract | Q36635830 | ||
| Statin-associated adverse effects beyond muscle and liver toxicity | Q36649124 | ||
| Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. | Q36773986 | ||
| Immortal time bias in pharmaco-epidemiology | Q37023172 | ||
| Human cholesterol metabolism and therapeutic molecules | Q37047547 | ||
| Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group. | Q37316208 | ||
| Risk of cataract in patients treated with statins. | Q38491966 | ||
| Cataract and the use of statins: a case-control study | Q39471379 | ||
| Population-based study on prevalence and risk factors of age-related cataracts in Peitou, Taiwan | Q39545947 | ||
| Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group | Q39605645 | ||
| Cholesterol and cataracts | Q41003223 | ||
| Expanded clinical evaluation of lovastatin (EXCEL) study results. II. Assessment of the human lens after 48 weeks of treatment with lovastatin | Q44096628 | ||
| Epidemiologic study of age-related cataracts among an elderly Chinese population in Shih-Pai, Taiwan | Q44161168 | ||
| Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes | Q45040932 | ||
| Recent statin use and cataract surgery | Q46213214 | ||
| Safety of statins | Q46288552 | ||
| Statin use and the long-term risk of incident cataract: the Blue Mountains Eye Study | Q50470525 | ||
| On the etiology of subcapsular lenticular opacities produced in dogs receiving HMG-CoA reductase inhibitors | Q68716206 | ||
| Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study | Q71664201 | ||
| Lovastatin and the human lens; results of a two year study. The MSDRL Study Group | Q72759905 | ||
| Persistence with statins and incident cataract: a population-based historical cohort study | Q82738915 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1017-1024 | |
| P577 | publication date | 2013-10-01 | |
| P1433 | published in | Drug Safety | Q15724462 |
| P1476 | title | Statin use and cataract surgery: a nationwide retrospective cohort study in elderly ethnic Chinese patients | |
| P478 | volume | 36 |
| Q39239492 | Changes in the Properties and Organization of Human Lens Lipid Membranes Occurring with Age. |
| Q39403936 | Cholesterol Bilayer Domains in the Eye Lens Health: A Review. |
| Q61447185 | Formal comment on "Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease" |
| Q38779059 | Organization of lipids in fiber-cell plasma membranes of the eye lens |
| Q35070254 | Properties of membranes derived from the total lipids extracted from clear and cataractous lenses of 61-70-year-old human donors |
| Q36243696 | Risk of hip/femur fractures during the initiation period of α-adrenoceptor blocker therapy among elderly males: a self-controlled case series study |
| Q37432533 | Statin Use and Incident Cataract Surgery: A Case-Control Study |
| Q36315609 | Statin Use and the Risk of Cataracts: A Systematic Review and Meta-Analysis |
| Q38285483 | Statins and Cataracts--a visual insight |
| Q54269575 | Statins use and risk of cataracts: firm conclusions are still far off. |
| Q89543608 | Use of Lipid-Lowering Drugs and the Risk of Cataract: A Population-Based Nested Case-Control Study |
| Q64948174 | Why Is Very High Cholesterol Content Beneficial for the Eye Lens but Negative for Other Organs? |
Search more.